跳至主要内容
临床试验/CTRI/2026/02/103112
CTRI/2026/02/103112尚未招募2 期

A SINGLE ARM CLINICAL TRIAL TO EVALUATE THE EFFICACY OF SAUBHAGYANANDAN GHRITA AND BALAADI CHURNA ON VANDHYATVA W.S.R TO ENDOMETRIAL RECEPTIVITY

National Institute of Ayurveda1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年5月15日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
40
试验地点
1

研究概览

简要总结

Female infertility is a significant reproductive health problem, and impaired endometrial receptivity is an important contributing factor. In Ayurveda, Vandhyatva is attributed to Dosha imbalance, Dhatu kshaya and dysfunction of Garbhashaya. Saubhagyanandana Ghrita and Balaadi Churna are classical Ayurvedic formulations with Balya, Brimhana and Garbhasthapana properties, which may improve uterine environment and endometrial receptivity.

This single arm clinical trial is designed to evaluate the efficacy of Saubhagyanandana Ghrita and Balaadi Churna in the management of female infertility with special reference to endometrial receptivity. Eligible participants will receive the study drugs for a fixed duration. Outcomes will be assessed using AppleBaum score usind ultrasonographic color doppler  evaluation of endometrial thickness and pattern.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Females in the age group 21-40 years, with active married life of minimum 1 year.
  • Patients having primary or secondary infertility with Applebaum’s scoring less than 13.

排除标准

  • 未提供

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Priyanka Carpenter

National Institute of Ayurveda

研究点 (1)

Loading locations...

相似试验